Xianheng International Science&Technology Co., Ltd.

SSE:605056.SS

14.44 (CNY) • At close May 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 639.7721,616.469805.169745.902438.0771,253.802672.981627.914373.229892.711468.529443.768318.739784.26387.523519.272301.469721.983454.571694.264120.057
Cost of Revenue 502.4461,102.562585.247527.866320.874808.118502.068429.611245.798498.834308.895266.052209.857421.974235.464312.366190.561409.928272.5426.6676.387
Gross Profit 137.326513.907219.921218.037117.203445.684170.913198.303127.431393.877159.634177.716108.882362.286152.059206.907110.908312.055182.071267.60443.67
Gross Profit Ratio 0.2150.3180.2730.2920.2680.3550.2540.3160.3410.4410.3410.40.3420.4620.3920.3980.3680.4320.4010.3850.364
Reseach & Development Expenses 13.83233.36212.10411.59810.58424.64310.5097.2677.75123.9169.6376.9745.92716.3885.3157.2564.6968.0349.5057.0073.364
General & Administrative Expenses 45.963-121.942145.302-13.61345.165-78.318122.247-11.95545.123-88.272110.78-24.17342.213-88.31148.07848.74339.441-89.00631.63778.07726.923
Selling & Marketing Expenses 66.11-38.745142.05176.48465.033142.92274.69672.13266.857106.18651.94861.54650.647124.3963.0554.24654.27976.09758.50875.95331.097
SG&A 112.073-160.687135.6762.872110.19864.604196.94360.177111.9817.914162.72937.37292.8636.078111.128102.98993.72-12.90990.145154.0358.02
Other Expenses -21.957455.176-152.031-0.408-0.44-0.002-0.724-0.363-0.75184.007-77.80375.053-0.414-0.551-0.59-0.026-0.0450.4060.104-1.0890.588
Operating Expenses 103.948327.851147.426162.366119.867283.954129.975147.142118.981225.83794.563119.39898.373230.956116.546110.13597.596153.52698.421161.45259.342
Operating Income 33.378186.05772.49645.24312.00664.78137.01723.53322.393142.79665.67255.08113.502121.02937.60788.71327.217141.37582.96193.893.828
Operating Income Ratio 0.0520.1150.090.0610.0270.0520.0550.0370.060.160.140.1240.0420.1540.0970.1710.090.1960.1830.1350.032
Total Other Income Expenses Net -0.92-0.407-0.005-0.408-0.44-0.002-0.724-0.363-0.444-0.681-0.546-1.2112.859-0.633-0.59-0.026-0.0450.4060.104-1.0890.588
Income Before Tax 32.458185.6572.49144.83511.56664.77936.29323.17121.949142.11565.12653.87126.361120.47837.01788.68627.172141.78183.06592.8014.416
Income Before Tax Ratio 0.0510.1150.090.060.0260.0520.0540.0370.0590.1590.1390.1210.0830.1540.0960.1710.090.1960.1830.1340.037
Income Tax Expense 10.08945.98116.278.9863.61219.2529.5610.3928.69537.04115.9157.9898.27529.69212.19115.5079.20626.52122.20726.263.536
Net Income 21.572126.14154.2433.7248.82535.69726.92621.07612.94496.80148.5443.93317.59383.89322.50674.9617.497110.6660.43463.6082.814
Net Income Ratio 0.0340.0780.0670.0450.020.0280.040.0340.0350.1080.1040.0990.0550.1070.0580.1440.0580.1530.1330.0920.023
EPS 0.050.320.140.0760.020.0910.0670.0530.0320.240.110.10.040.210.0640.210.050.320.170.230.01
EPS Diluted 0.050.320.140.0760.020.0910.0670.0530.0320.240.110.10.040.210.0640.210.050.320.170.230.01
EBITDA 32.669185.63273.157.14324.03877.9648.1433.36831.58143.03165.30363.68736.088128.44537.75396.77213.313146.90985.83592.764.483
EBITDA Ratio 0.0510.1150.0910.0770.0550.0620.0720.0530.0850.160.1390.1440.1130.1640.0970.1860.0440.2030.1890.1340.037